In a 12-week open-label study on patients with rheumatoid arthritis, methotrexate was also reported to enhance adenosine-induced vasodilation (determined by forearm blood flow measurement and adenosine deaminase activity in erythrocytes and lymphocytes) [52]. Here, ADA is linked to rheumatoid arthritis.